Hello,

Sign up to join our community!

Welcome Back,

Please sign in to your account!

Forgot Password,

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.

Sorry, you do not have permission to ask a question, You must login to ask a question.

Estrace: Uses, dosage, side effects, warnings & patient reviews

Estrace

Estrace

Estradiol
Estrace is a prescription medication containing micronized estradiol, a form of estrogen. It is indicated for the management of menopausal symptoms, vaginal atrophy, and the prevention of postmenopausal osteoporosis. It is classified under women's health drugs.
  • ActiveIngredient: Estradiol
  • DosageForm: Oral tablets
  • Dosage: 0.5 mg, 1 mg, 2 mg.
  • Indications: Treatment of moderate to severe vasomotor symptoms associated with menopause; Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with menopause; Treatment of hypoestrogenism due to hypogonadism, castration, or primary ovarian failure; Prevention of postmenopausal osteoporosis; Palliative treatment of metastatic breast cancer and advanced androgen-dependent carcinoma of the prostate.
  • Manufacturer: Bristol-Myers Squibb (Original); generic manufacturers include Amneal Pharmaceuticals, Teva Pharmaceuticals, and Viatris (Mylan).
  • Storage: Store at controlled room temperature, typically 20°C to 25°C (68°F to 77°F), and protect from light and moisture.
  • Drug Status: Prescription Only

What is Estrace (Estradiol)?

Estrace is an oral prescription medication for hormone replacement therapy (HRT). Its active ingredient is micronized estradiol, a bioidentical form of the primary female sex hormone, 17-beta-estradiol. It is chemically identical to the estrogen produced by the ovaries.

The medication works by binding to estrogen receptors in target tissues throughout the body. This action replaces the estrogen that the body ceases to produce in adequate amounts after menopause. By replenishing estrogen levels, it helps to stabilize hormonal fluctuations that cause symptoms.

Estrace tablets are micronized, meaning the estradiol particles are reduced in size to enhance absorption from the gastrointestinal tract. This increases its bioavailability compared to older, non-micronized estrogen formulations.

Available Forms

Estrace is most commonly available as oral tablets in various strengths. It is also available as a topical Estrace vaginal cream, which is applied locally to treat symptoms of vaginal atrophy, such as dryness, burning, and painful intercourse.

How to Take Estrace

Estrace must be taken exactly as prescribed by a healthcare provider. Therapy should be initiated at the lowest effective dose and for the shortest duration consistent with treatment goals and individual risks.

Administration

Oral Estrace tablets are taken by mouth, typically once daily. They may be taken with or without food. Consistent daily intake is recommended.

For Estrace vaginal cream, application instructions are specific and provided by the prescribing physician or pharmacist. It is inserted into the vagina using an applicator. The dosage and frequency for vaginal use differ significantly from oral therapy.

Duration of Therapy

Treatment duration is individualized. For vasomotor symptoms (hot flashes), therapy is generally recommended for the shortest possible time. For osteoporosis prevention, the need for continued therapy should be re-evaluated periodically.

Missed Dose

If a dose is missed, it should be taken as soon as remembered. If it is close to the time for the next dose, the missed dose should be skipped. A double dose should not be taken to make up for a missed dose.

Side Effects of Estrace

Estrogen therapy is associated with a range of potential side effects, from common and mild to serious and rare. Patients should be monitored by their healthcare provider.

Common and Serious Side Effects of Estrace
FrequencySide Effects
Common
  • Headache
  • Nausea and vomiting
  • Abdominal pain or bloating
  • Breast tenderness or enlargement
  • Irregular vaginal bleeding or spotting
  • Fluid retention and swelling
Less Common / Serious
  • Severe headaches, vision changes (possible migraine)
  • Jaundice (yellowing of skin/eyes), which may indicate liver problems
  • Unusual vaginal bleeding
  • Lumps in the breast
  • Mental/mood changes (e.g., depression, memory loss)
  • Severe stomach/abdominal pain (potential for gallbladder disease such as cholecystitis)
  • Darkening of facial skin (melasma)
Serious (Require Immediate Medical Attention)
  • Sudden severe headache, confusion, trouble speaking/seeing (signs of a cerebrovascular event)
  • Chest pain, shortness of breath, coughing up blood (signs of pulmonary embolism)
  • Pain/swelling/warmth in the leg (signs of deep vein thrombosis)
  • Sudden loss of coordination, severe dizziness/fainting
  • Allergic reaction (rash, itching/swelling, severe dizziness, trouble breathing)

What is Estrace Used For?

Estrace is indicated for specific conditions related to estrogen deficiency in postmenopausal women.

FDA-Approved Uses

  • Moderate to Severe Vasomotor Symptoms: Estrace is prescribed for the management of menopausal symptoms such as hot flashes and night sweats. For more information on managing this transition, see our resource on menopause.
  • Vulvar and Vaginal Atrophy: It is indicated for treating symptoms of vaginal dryness, itching, burning, and dyspareunia (painful intercourse), often associated with menopause. The Estrace vaginal cream is specifically formulated for this local treatment.
  • Prevention of Postmenopausal Osteoporosis: Estrace may be used to prevent bone loss and reduce the risk of fractures in women at significant risk of osteoporosis. It should be considered only for women who cannot tolerate non-estrogen medications. Alternative treatments, such as selective estrogen receptor modulators (SERMs) like Evista, are also available.

Important Treatment Principle

When prescribing Estrace for a woman with an intact uterus, a progestin must also be added to reduce the risk of endometrial hyperplasia and carcinoma. This is not necessary for women who have had a hysterectomy.

Interactions Alcohol:

Consult your doctor
Consumption of alcohol may increase the risk of certain side effects associated with Estrace, particularly headache and nausea. It may also affect liver metabolism of the hormone. Patients should discuss their alcohol use with their prescribing physician.

Interactions Other Medications:

Consult your doctor
Estrace can interact with many medications. It may increase the effects of corticosteroids like prednisone. Some medications, such as certain antibiotics (e.g., ampicillin), anticonvulsants, and St. John's Wort, can reduce the effectiveness of estradiol by increasing its metabolism. A comprehensive review of all concurrent medications is essential.

Special Groups Pregnancy:

Unsafe
Estrace is contraindicated during pregnancy. Estrogen exposure to the fetus can cause birth defects. For guidance on medication use during pregnancy, refer to this resource.

Special Groups Breastfeeding:

Unsafe
Estrace is not recommended for use during breastfeeding. Estradiol is excreted in human milk and may affect milk production and the nursing infant.

Special Groups Elderly:

Use with caution
Elderly patients may be at increased risk for certain complications of estrogen therapy, including dementia, stroke, and breast cancer. The lowest effective dose should be used.

Special Groups Children:

Unsafe
Estrace is not indicated for use in children.

Effects on Activities Driving:

Use with caution
Estrace may cause dizziness in some individuals. Patients should assess their individual response before driving.

Effects on Activities Operating Machinery:

Use with caution
The same caution applies to operating machinery. Patients should be aware of the potential for dizziness or headaches.

Important Safety Concerns and Considerations

Boxed Warning (Black Box Warning)

Estrace carries a U.S. Food and Drug Administration (FDA) Boxed Warning, the strongest safety alert, regarding several serious risks:

  • Endometrial Cancer: Use of unopposed estrogen in women with an intact uterus increases the risk of endometrial cancer. Adding a progestin reduces this risk. Any abnormal vaginal bleeding should be investigated.
  • Cardiovascular and Thromboembolic Risks: Estrogen and estrogen/progestin therapy increase the risk of cardiovascular events (e.g., heart attack), stroke, and venous thromboembolism (e.g., deep vein thrombosis, pulmonary embolism).
  • Breast Cancer: Estrogen-progestin therapy has been reported to increase the risk of invasive breast cancer. Regular breast exams and mammograms are advised.
  • Dementia: In postmenopausal women aged 65 years or older, estrogen and estrogen-progestin therapy may increase the risk of developing dementia.

Other Significant Risks

  • Gallbladder Disease: Estrogen therapy increases the risk of gallbladder disease requiring surgery.
  • Hypercalcemia: In women with breast cancer and bone metastases, estrogen may cause severe hypercalcemia.
  • Visual Abnormalities: Discontinuation should be considered if there is a sudden onset of vision loss, proptosis, diplopia, or migraine.
  • Elevated Blood Pressure: Blood pressure should be monitored during estrogen use.

Critical Warnings for Estrace Use

Contraindications

Estrace is contraindicated and must not be used in women with any of the following conditions:

  • Undiagnosed abnormal genital bleeding.
  • Known, suspected, or history of breast cancer (except in specific circumstances for metastatic disease under specialist care).
  • Known or suspected estrogen-dependent neoplasia, such as cancer of the uterus.
  • Active or history of arterial thromboembolic disease (e.g., stroke, heart attack).
  • Active or history of venous thromboembolism (DVT, PE).
  • Liver dysfunction or disease.
  • Known protein C, protein S, or antithrombin deficiency, or other known thrombophilic disorders.
  • Known or suspected pregnancy.

Precautions and Monitoring

  • Physical Examination: A complete medical and family history should be taken prior to initiation, with attention to thromboembolic, cardiovascular, and oncologic risks. A physical exam, including blood pressure, breast, abdominal, and pelvic exams, is recommended.
  • Hypertriglyceridemia: Women with pre-existing hypertriglyceridemia require monitoring, as estrogen therapy may elevate plasma triglycerides, leading to pancreatitis.
  • Impaired Liver Function: Estrogens may be poorly metabolized in patients with impaired liver function and should be administered with caution.
  • Hypothyroidism: Women on thyroid hormone replacement therapy may require increased doses of thyroid hormone, as estrogen may increase thyroid-binding globulin levels.
  • Fluid Retention: Estrogens may cause some degree of fluid retention, which may exacerbate conditions such as asthma, epilepsy, migraine, and cardiac or renal dysfunction.

Estrace Dosage Information

Dosing is highly individualized based on the indication, patient response, and risk profile. The following are general guidelines; the prescribing physician’s instructions must be followed.

General Estrace (Estradiol) Oral Dosage Guidelines
IndicationTypical Starting DosageNotes
Moderate to Severe Vasomotor Symptoms0.5 mg to 1 mg orally once daily.Dose should be titrated to the lowest effective dose. Therapy should be re-evaluated periodically.
Vulvar and Vaginal Atrophy0.5 mg orally once daily.Alternatively, Estrace Vaginal Cream is dosed as 2 to 4 grams intravaginally daily for 1–2 weeks, then reduced to half the initial dose for 1–2 weeks, followed by a maintenance dose of 1 gram 1–3 times per week.
Prevention of Postmenopausal Osteoporosis0.5 mg orally once daily.Should be considered only for women at significant risk of osteoporosis. The need for continued therapy should be reassessed regularly.

Important Administration Notes

  • Cyclic vs. Continuous Regimen: For women with an intact uterus, Estrace is often administered cyclically (e.g., 21-25 days of estrogen followed by 5-10 days of progestin) or continuously with a daily progestin to oppose endometrial effects.
  • Dose Adjustment: Dosage may be adjusted based on clinical response and side effects. The goal is to use the lowest dose that controls symptoms.
  • Discontinuation: When discontinuing therapy, a gradual tapering of the dose may be considered to minimize the return of menopausal symptoms.

Drug Interactions with Estrace

Estradiol can interact with numerous medications, potentially altering their effects or the effects of Estrace itself. A complete list of all medications (prescription, OTC, and herbal) must be shared with the healthcare provider.

Significant Drug Interactions with Estrace (Estradiol)
Interacting Substance Class/ExamplesEffect of Interaction
Enzyme Inducers
(e.g., carbamazepine, phenytoin, rifampin, St. John’s Wort)
Can increase the metabolism of estradiol, leading to decreased plasma concentrations and potential reduction in therapeutic effect.
Corticosteroids
(e.g., prednisone)
Estrogens may potentiate the anti-inflammatory effects of corticosteroids, potentially increasing the risk of corticosteroid side effects.
Anticoagulants
(e.g., warfarin)
Estrogens may increase or decrease the anticoagulant effect. Prothrombin time (INR) should be monitored closely.
Antibiotics
(e.g., ampicillin, tetracyclines)
Some broad-spectrum antibiotics may reduce enterohepatic recirculation of estrogens by altering gut flora, potentially decreasing estrogen levels.
Hepatic Metabolized Drugs
(e.g., certain benzodiazepines, beta-blockers, cyclosporine, theophylline)
Estrogens may inhibit the metabolism of these drugs, potentially increasing their plasma levels and risk of toxicity.
Thyroid HormoneEstrogen increases thyroid-binding globulin (TBG), which may increase the total thyroid hormone level. Dose adjustment of thyroid replacement therapy may be needed.

FAQs

Symptom relief, particularly for vasomotor symptoms like hot flashes, may begin within a few weeks of starting therapy. Maximum benefit is often achieved within a few months. If symptoms are not adequately controlled, the dosage may be adjusted by the physician.
Estrogen therapy can cause fluid retention, which may be perceived as weight gain. It may also influence fat distribution. Not all women experience significant weight change. Any concerns should be discussed with a healthcare provider.
Estrace is not specifically FDA-approved for the treatment of low sexual desire (hypoactive sexual desire disorder, or HSDD). While treating vaginal atrophy may improve comfort during intercourse, it does not directly increase libido. Other medications, such as Addyi (flibanserin), are approved for HSDD in premenopausal women.
Yes. Estrace contains micronized estradiol, which is chemically identical to human estradiol. Premarin contains conjugated estrogens derived from pregnant mares' urine, which is a mixture of several estrogens, some not identical to human estrogens. They are both effective for menopausal symptoms but have different compositions.
Irregular vaginal bleeding is common when starting hormone therapy. However, any unusual, persistent, or heavy vaginal bleeding should be reported to your healthcare provider immediately for evaluation, as it may require diagnostic procedures to rule out endometrial pathology.

Additional Information

Storage and Handling

Store Estrace tablets and vaginal cream at room temperature (between 20°C to 25°C or 68°F to 77°F), in a tightly closed container, away from light, excess heat, and moisture. Keep out of reach of children and pets.

Historical and Clinical Context

Estradiol, the active ingredient in Estrace, has been used in hormone replacement therapy for decades. The formulation as a micronized tablet improved its oral bioavailability. Landmark studies like the Women’s Health Initiative (WHI) in the early 2000s significantly changed prescribing practices by quantifying the risks and benefits, leading to the current principle of using the lowest effective dose for the shortest duration.

Off-Label Uses

Under physician direction, Estrace may sometimes be used in the management of certain conditions like hypoestrogenism due to hypogonadism, castration, or primary ovarian failure. In some complex gynecological regimens, it may be part of a treatment plan for conditions like endometriosis, often in conjunction with other agents such as progestins or danazol. These uses are not FDA-approved for Estrace.

Reporting Side Effects

Patients and healthcare providers are encouraged to report negative side effects or quality issues to the relevant national health authority (e.g., the FDA in the United States via the MedWatch program).

References and Medical Sources

  1. U.S. Food and Drug Administration (FDA). Estrace (estradiol) Tablets Prescribing Information. [Revised 2023]. https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/081295s014,084499s042,084500s044lbl.pdf
  2. The North American Menopause Society (NAMS). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. 2022.
  3. MedlinePlus. Estradiol. U.S. National Library of Medicine; [Updated 2022]. https://medlineplus.gov/druginfo/meds/a682922.html
  4. Rossouw, J.E., et al. Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women’s Health Initiative Randomized Controlled Trial. JAMA. 2002.
  5. Drugs.com. Estradiol Professional Monograph. Drugs.com; [Updated 2024]. https://www.drugs.com/monograph/estradiol.html

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.

1 User Review

  1. My doctor put me on Estrace cream after menopause hit and things got… well, uncomfortable down there, if you know what I mean. I was a bit hesitant, but it was really affecting things. The first few times I used it, maybe a tiny bit of irritation, but that settled down super quick. And honestly, what a difference it’s made. So much more comfortable now. Really glad I decided to go for it. It’s just made daily life that bit easier.

You must login to add a comment.

Popular Questions

Top Members

Question 1

How do you take Estrace?

Question 2

Have you experienced any side effects while taking Estrace?

Question 3

How much has your condition improved since starting Estrace?

Question 4

What do you use Estrace for?

We sincerely appreciate you taking the time to share your feedback. Every user's perspective is valuable to us.

Ask to get answers.